ACW.AX · ACTINOGEN MEDICAL LIMITED
Australia · RS rating 67 · As of 2026-10-14
| Price | 0.05 AUD |
|---|---|
| 1-day change | +5.7% |
| RS rating (overall / 1M / 3M / 12M) | 67 / 15 / 78 / 91 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 27 / 23 / 10 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +33.6% |
| Market cap (USD) | $148.3M |